Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 436 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Efficacy of G-CSF-Priming in Elderly AML Patients				Phase IV				AML-elderly 01/99 Trial NCT00199147
	AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia				Phase IV				MK1-192 NCT00180128
	Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC				Phase IV				AML_GT60_DD NCT00180167
	Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)				Phase IV				LPA 2005 NCT00408278
	Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)				Phase IV				LAP-R2007 NCT00504764
	Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors				Phase IV				2006-00055-18 NCT00415103
	Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic				Phase IV				30052004 NCT00196768
	Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer				Phase III, Phase II				RPCI-RP-9815 NCI-V99-1527, NCT00003816, RP 98-15
	Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia				Phase III, Phase II				AMLSG07-04 NCT00151242
	Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)				Phase III, Phase II				Levosta-CBF-02/04 NCT00215007


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute